PREVIOUSLY DEVELOPED SYSTEMS-BASED BIOPSY MODEL (PROSTATE PX plus ) IDENTIFIES FAVORABLE-RISK PROSTATE CANCER FOR MEN ENROLLED IN AN ACTIVE SURVEILLANCE PROGRAM

被引：4
|
作者：
Donovan, Michael
Khan, Faisal
Powell, Douglas
Fernandez, Gerardo
Feliz, Aaron
Hansen, Thomas
Bernardino, Lourdes
Capodieci, Paola
Bayer-Zubek, Valentina
Liu, Quihua
Vance, Rav
Klotz, Laurence
机构：
来源：
JOURNAL OF UROLOGY | 2011年 / 185卷 / 04期
关键词：
D O I：
10.1016/j.juro.2011.02.993
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1293
引用
收藏
页码：E517 / E518
页数：2
相关论文
共 50 条
  • [1] ACTIVE SURVEILLANCE FOR FAVORABLE-RISK PROSTATE CANCER: AN UPDATE OF THE UNIVERSITY OF MIAMI PROGRAM
    Soloway, Mark S.
    Eldefrawy, Ahmed
    Manoharan, Murugesan
    Iremashvili, Viacheslav
    [J]. JOURNAL OF UROLOGY, 2013, 189 (04): : E273 - E274
  • [2] Thoughts on Criteria for Active Surveillance of Favorable-risk Prostate Cancer
    Gettman, Matthew T.
    [J]. EUROPEAN UROLOGY, 2016, 70 (06) : 961 - 962
  • [3] Exploring Variation in the Receipt of Recommended Active Surveillance for Men with Favorable-Risk Prostate Cancer
    Radhakrishnan, Archana
    Wallner, Lauren P.
    Skolarus, Ted A.
    George, Arvin K.
    Rosenberg, Bradley H.
    Abrahamse, Paul
    Hawley, Sarah T.
    [J]. JOURNAL OF UROLOGY, 2022, 208 (03): : 600 - 608
  • [4] Active Surveillance for Favorable-Risk Prostate Cancer: A Short Review
    Lawrentschuk, Nathan
    Klotz, Laurence
    [J]. KOREAN JOURNAL OF UROLOGY, 2010, 51 (10) : 665 - 670
  • [5] THE IMPACT OF CONFIRMATORY TESTING ON THE ADOPTION OF ACTIVE SURVEILLANCE FOR MEN WITH FAVORABLE-RISK PROSTATE CANCER
    Kaye, Deborah
    Qi, Ji
    Morgan, Todd
    Linsell, Susan
    Lane, Brian
    Montie, James
    Miller, David
    Cher, Michael
    [J]. JOURNAL OF UROLOGY, 2018, 199 (04): : E205 - E205
  • [6] Oncological Outcomes in Men With Favorable Intermediate Risk Prostate Cancer Enrolled in Active Surveillance
    Pepe, Pietro
    Pepe, Ludovica
    Pennisi, Michele
    Fraggetta, Filippo
    [J]. IN VIVO, 2024, 38 (03): : 1300 - 1305
  • [7] Active surveillance for favorable-risk prostate cancer: who, how and why?
    Klotz, Laurence
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2007, 4 (12): : 692 - 698
  • [8] Active surveillance for favorable-risk prostate cancer: who, how and why?
    Laurence Klotz
    [J]. Nature Clinical Practice Oncology, 2007, 4 : 692 - 698
  • [9] ACTIVE SURVEILLANCE FOR FAVORABLE-RISK PROSTATE CANCER IN AFRICAN CARIBBEAN MEN: RESULTS OF A PROSPECTIVE STUDY
    Meunier, Matthias
    Eyraud, Remi
    Senechal, Cedric
    Gourtaud, Gilles
    Roux, Virginie
    Lanchon, Cecilia
    Brureau, Laurent
    Blanchet, Pascal
    [J]. JOURNAL OF UROLOGY, 2017, 197 (04): : E561 - E562
  • [10] A PROSPECTIVE, LONGITUDINAL ACTIVE SURVEILLANCE PROGRAM FOR FAVORABLE-RISK PROSTATE CANCER: LONG TERM OUTCOMES
    Tosoian, Jeffrey
    Mamawala, Mufaddal
    Epstein, Jonathan
    Landis, Patricia
    Wolf, Sacha
    Trock, Bruce
    Carter, H. Ballentine
    [J]. JOURNAL OF UROLOGY, 2015, 193 (04): : E147 - E147
12345